M&A TRANSACTION · 2025
Horizon Infusions acquired by Rubicon
$130.0M· Pharmacy
Acquirer
Rubicon
Disclosed financials at time of acquisition
Revenue
-
EBITDA
$8.0M
Deal Value
$130.0M
What's your pharmacy worth today?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Context
This $130.0M acquisition of Horizon Infusions by Rubicon sits in the pharmacy sub-vertical. Run a valuation for your own pharmacy business via our Pharmacy valuation hub.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own pharmacy
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Compare your business to the Horizon Infusions acquisition.
More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Value a pharmacy· run the calculator
- Pharmacy median multiples· real-deal benchmarks
- Who buys pharmacy businesses?· active buyers
- Who acquired University Compounding Pharmacy?· buyer profile
- How to value a pharmacy· long-form guide
Citation: ExitValue.ai. (2025). Horizon Infusions acquired by Rubicon. https://exitvalue.ai/deals/horizon-infusions-acquired-by-rubicon-hc-2025-0016